Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 23, Issue 9, Pages 1046-1054
Publisher
Springer Nature
Online
2017-08-14
DOI
10.1038/nm.4372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
- (2016) Richard Marcotte et al. CELL
- Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
- (2016) Shaokun Shu et al. NATURE
- The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
- (2016) William J Gibson et al. NATURE GENETICS
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β–dependent mechanisms
- (2016) Xiarong Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting BET bromodomain proteins in solid tumors
- (2016) Vaibhav Sahai et al. Oncotarget
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Structural and kinetic analysis of the COP9-Signalosome activation and the cullin-RING ubiquitin ligase deneddylation cycle
- (2016) Ruzbeh Mosadeghi et al. eLife
- Functions of BET proteins in erythroid gene expression
- (2015) Aaron J. Stonestrom et al. BLOOD
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- (2015) M. Boi et al. CLINICAL CANCER RESEARCH
- Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation
- (2015) Jian An et al. MOLECULAR CELL
- SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression
- (2015) Wenjian Gan et al. MOLECULAR CELL
- Beating the odds: BETs in disease
- (2015) Chen-Yi Wang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
- (2015) Mirjam Blattner et al. NEOPLASIA
- Translating Genomics for Precision Cancer Medicine
- (2014) Roychowdhury Sameek et al. Annual Review of Genomics and Human Genetics
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
- (2014) J.-P. P. Theurillat et al. SCIENCE
- Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
- (2014) Siân Jones et al. Nature Communications
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Integrated proteomic analysis of post-translational modifications by serial enrichment
- (2013) Philipp Mertins et al. NATURE METHODS
- Large-scale identification of ubiquitination sites by mass spectrometry
- (2013) Namrata D Udeshi et al. Nature Protocols
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- (2013) C. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
- (2012) Peter J. Wild et al. EMBO Molecular Medicine
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
- (2012) Matthieu Le Gallo et al. NATURE GENETICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for a Reciprocal Regulation between SCF and CSN
- (2012) Radoslav I. Enchev et al. Cell Reports
- KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
- (2011) A. Mortezavi et al. CLINICAL CANCER RESEARCH
- TRIM24 links a non-canonical histone signature to breast cancer
- (2010) Wen-Wei Tsai et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Combined PTEN and p27kip1 Protein Expression Patterns Are Associated with Obesity and Prognosis in Endometrial Carcinomas
- (2009) A. Dellas et al. CLINICAL CANCER RESEARCH
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
- (2009) Min Zhuang et al. MOLECULAR CELL
- Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions
- (2008) A Lebeau et al. JOURNAL OF PATHOLOGY
- Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells
- (2008) Sean C. Bendall et al. MOLECULAR & CELLULAR PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started